Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MaxCyte, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

MaxCyte develops and commercializes cell-engineering platforms using proprietary electroporation technology for loading cells with biomolecules. The company enables biopharmaceutical developers to create cell-based therapeutics including CAR-T and other immunotherapies.